MetaCap

Achieve Life Sciences (QUIT) vs Alpha Teknova (TKNO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Achieve Life Sciences is the larger company by market cap ($573.2 million vs $480.0 million), about 1.2 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

QUIT-25.87%TKNO+5.68%
+32%+2%-29%
Aug 17, 20261 yearNov 20, 2026
QUIT-30.41%TKNO+3.67%
+30%-2%-33%
Aug 17, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

QUIT versus TKNO key metrics
MetricQUITTKNO
Share price$5.56$7.63
Market cap$573.25M$479.95M
1-day change-5.28%-2.30%
YTD return—+100.79%
1-year return—+77.44%
5-year return—-63.63%
EPS (TTM)$-1.71$-0.30
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$40.52M
Revenue growth (YoY)—+7.35%
Net income (latest FY)$-54.65M$-17.26M
Gross margin—33.17%
Operating margin—-41.90%
Net margin—-42.59%
52-week high$8.64$9.48
52-week low$2.62$1.91
Distance from 52-week high-35.65%-19.51%
Analyst consensusstrong_buynone
Avg. price target upside+162.23%+28.83%
Average volume1.38M437.31K
Shares outstanding103.10M62.90M
Employees28158
SectorHealth CareHealth Care
IndustryBiotechnology: In Vitro & In Vivo Diagnostic SubstancesBiotechnology: In Vitro & In Vivo Diagnostic Substances

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Achieve Life Sciences

QUIT stock →

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms.

Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 28 employees

About Alpha Teknova

TKNO stock →

Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.

Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 158 employees

QUIT vs TKNO FAQ

Which is bigger, Achieve Life Sciences or Alpha Teknova?

Achieve Life Sciences (QUIT) is larger, with a market capitalization of $573.25M compared with $479.95M for Alpha Teknova (TKNO).

Are Achieve Life Sciences and Alpha Teknova in the same industry?

Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.

More comparisons